<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01932294</url>
  </required_header>
  <id_info>
    <org_study_id>Medamacs</org_study_id>
    <nct_id>NCT01932294</nct_id>
  </id_info>
  <brief_title>Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support</brief_title>
  <acronym>Medamacs</acronym>
  <official_title>Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medamacs is a prospective, observational study of ambulatory patients with advanced heart&#xD;
      failure. The study enrolls patients who have not yet received a Left Ventricular Assist&#xD;
      Device (LVAD) but who receive their care at a hospital with a Joint Commission certified&#xD;
      mechanical circulatory support program.&#xD;
&#xD;
      Medamacs is funded through the Interagency for Mechanically Assisted Circulatory Support&#xD;
      (INTERMACS) NHLBI Contract.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants between 18 and 80 years old with low ejection fraction history and&#xD;
      hospitalization for heart failure within the past year will be screened for the study. All&#xD;
      subjects who have been admitted to the heart failure service will be screened and recruited,&#xD;
      either as an inpatient or during their first outpatient follow-up appointment by the&#xD;
      investigator and research staff caring for patients in the advanced heart failure program.&#xD;
&#xD;
      Eligibility for enrollment will be based only upon information that is clinically available&#xD;
      at the time of screening. The history of prior hospitalizations will be available from&#xD;
      clinical records.&#xD;
&#xD;
      Routine evaluation and triage of ambulatory patients with advanced heart disease includes&#xD;
      echocardiography and functional assessment with peak oxygen consumption and frequently 6&#xD;
      minute walk distance. The elements of information required for estimation of the Seattle&#xD;
      Heart Failure Risk score will be gleaned from laboratory data, or imputed as described in the&#xD;
      Seattle score literature. The research coordinator will enter this data onto a currently&#xD;
      available website for calculation of the Seattle score.&#xD;
&#xD;
      Eligibility will be determined by the inclusion and exclusion criteria and the study research&#xD;
      team will approach individual subjects who are potential candidates for participation once&#xD;
      the subject's primary physician has given permission to approach. Only persons with a&#xD;
      scientific or ethical reason will be excluded. Incarcerated prisoners have been excluded by&#xD;
      this protocol.&#xD;
&#xD;
      Participants will be followed every 6 months for 24 months after two baseline visits. The 6&#xD;
      month and 18 month follow ups consist of telephone interviews. Follow ups at 12 months and 24&#xD;
      months consists of routine clinical visits.&#xD;
&#xD;
      Approximately 350 patients from 12 centers in the United States will be enrolled over a 12&#xD;
      month period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">January 20, 2017</completion_date>
  <primary_completion_date type="Actual">January 20, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Number of Heart Failure Participants Deceased at 24 Months</measure>
    <time_frame>6 month intervals after the baseline visit up to 24 months</time_frame>
    <description>Death after the baseline visit up to 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Known Ventricular Assist Device (VAD) Implantation</measure>
    <time_frame>6 month intervals after the baseline visit up to 24 months</time_frame>
    <description>Known VAD implantation after the baseline visit up to 24 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Known Heart Transplantation</measure>
    <time_frame>6 month intervals after the baseline visit up to 24 months</time_frame>
    <description>Heart transplantation after the baseline visit up to 24 months</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">171</enrollment>
  <condition>Heart Failure</condition>
  <condition>Systolic Heart Failure</condition>
  <arm_group>
    <arm_group_label>MedaMACS participants</arm_group_label>
    <description>All participants who have met the inclusion criteria.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be screened for this study if they are between 18 and 80 years old with&#xD;
        low ejection fraction history and hospitalization for heart failure within the past year.&#xD;
        All subjects who have been admitted to the heart failure service will be screened and&#xD;
        recruited for study participation, either as an inpatient or during their first outpatient&#xD;
        follow-up appointment by the investigator and research staff caring for patients in the&#xD;
        advanced heart failure program of the enrolling center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:&#xD;
&#xD;
        Patients with Advanced Heart Failure&#xD;
&#xD;
          1. Age 18-80 years&#xD;
&#xD;
          2. New York Heart Association class III-IV heart failure for 45 of the last 60 days&#xD;
&#xD;
          3. Left ventricular ejection fraction ≤ 35%&#xD;
&#xD;
          4. Heart failure diagnosis or typical symptoms for 12 months&#xD;
&#xD;
          5. Use of evidence based oral medications (beta-blockers, ACE-inhibitors/ARBs,&#xD;
             aldosterone antagonist) for at least 3 months prior to enrollment or documented&#xD;
             medication contraindication or intolerance.&#xD;
&#xD;
          6. Hospitalization for heart failure within the previous 12 months (other than for&#xD;
             elective procedure)&#xD;
&#xD;
          7. Informed consent given&#xD;
&#xD;
        In Addition, they must have at least one of the following:&#xD;
&#xD;
        An additional unplanned hospitalization during the previous 12 months for a total of at&#xD;
        least 2 inpatient hospitalizations lasting &gt;24 hours with heart failure as the primary or&#xD;
        secondary diagnosis within the previous 12 months&#xD;
&#xD;
        OR&#xD;
&#xD;
          1. Peak oxygen uptake (VO2) &lt;55% of age- and sex-predicted (using Wasserman equation) OR&#xD;
             a peak VO2 ≤16 ml/kg/min for men and ≤14 ml/kg/min for women in a test with an RER&#xD;
             &gt;1.08 on cardiopulmonary exercise testing.&#xD;
&#xD;
          2. 6-minute walk distance &lt;300 meters without non-cardiac limitation.&#xD;
&#xD;
          3. Serum BNP &gt; 1000 (NT-proBNP &gt; 4000 pg/ml) as outpatient or at hospital discharge.&#xD;
&#xD;
        OR&#xD;
&#xD;
        Seattle Heart Failure Model Score &gt; 1.5.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
          1. Age &gt;80 years or &lt;18 years&#xD;
&#xD;
          2. Non-cardiac diagnosis anticipated to limit 2-year survival (≥30-50% mortality within 2&#xD;
             years from non-cardiac diagnosis)&#xD;
&#xD;
          3. Primary functional limitation from non-cardiac diagnosis even if not likely to limit&#xD;
             survival&#xD;
&#xD;
          4. QRS &gt; 120msec and planned biventricular pacemaker implant or biventricular pacemaker&#xD;
             implantation within past 90 days&#xD;
&#xD;
          5. Current home intravenous inotrope therapy&#xD;
&#xD;
          6. Chronic hemodialysis or peritoneal dialysis&#xD;
&#xD;
          7. Scheduled for non-ventricular assist device cardiac surgery on current hospital&#xD;
             admission&#xD;
&#xD;
          8. Obvious anatomical or other major contra-indication to any cardiac surgery in the&#xD;
             future (e.g. previous pneumonectomy, advanced connective tissue disease)&#xD;
&#xD;
          9. Actively listed for heart transplant as UNOS Status 1 or 2&#xD;
&#xD;
         10. History of cardiac amyloidosis&#xD;
&#xD;
         11. Dominant lesion of at least moderate aortic or mitral stenosis or congenital&#xD;
             structural heart defect.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James K Kirklin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>INTERMACS Principal Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.intermacs.org</url>
    <description>Click here for more information about this study: MedaMACS</description>
  </link>
  <reference>
    <citation>Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013 Feb;32(2):141-56. doi: 10.1016/j.healun.2012.12.004. Erratum in: J Heart Lung Transplant. 2015 Oct;34(10):1356. Timothy Baldwin, J [corrected to Baldwin, J T].</citation>
    <PMID>23352390</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>April 12, 2013</study_first_submitted>
  <study_first_submitted_qc>August 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2013</study_first_posted>
  <results_first_submitted>September 20, 2018</results_first_submitted>
  <results_first_submitted_qc>November 8, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 6, 2018</results_first_posted>
  <last_update_submitted>November 8, 2018</last_update_submitted>
  <last_update_submitted_qc>November 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Advanced Heart Failure</keyword>
  <keyword>Refractory Heart Failure</keyword>
  <keyword>Mechanical Circulatory Support Device</keyword>
  <keyword>Ventricular Assist Device</keyword>
  <keyword>Medamacs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data (IPD) is not available. De-identified datasets may be available upon approval.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 16, 2012</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/94/NCT01932294/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>MedaMACS Participants</title>
          <description>All participants who have met the inclusion criteria.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="171"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="72"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="99"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>VAD Implantation</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Heart Transplantation</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Transferred to other hospitals</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>MedaMACS Participants</title>
          <description>All participants who have met the inclusion criteria.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="171"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>1 participant missed this variable</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="170"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.03" spread="10.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>One participant missing a value for the variable</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="170"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Heart Failure Participants Deceased at 24 Months</title>
        <description>Death after the baseline visit up to 24 months</description>
        <time_frame>6 month intervals after the baseline visit up to 24 months</time_frame>
        <population>By the end of the follow-up, 43 patients had deceased.</population>
        <group_list>
          <group group_id="O1">
            <title>MedaMACS Participants</title>
            <description>All participants who have met the inclusion criteria. By the end of the follow-up, 43 out of 171 patients died.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Heart Failure Participants Deceased at 24 Months</title>
          <description>Death after the baseline visit up to 24 months</description>
          <population>By the end of the follow-up, 43 patients had deceased.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="171"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Known Ventricular Assist Device (VAD) Implantation</title>
        <description>Known VAD implantation after the baseline visit up to 24 months</description>
        <time_frame>6 month intervals after the baseline visit up to 24 months</time_frame>
        <population>Patients with known endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>MedaMACS Participants</title>
            <description>All participants who have met the inclusion criteria.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Known Ventricular Assist Device (VAD) Implantation</title>
          <description>Known VAD implantation after the baseline visit up to 24 months</description>
          <population>Patients with known endpoints.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="171"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Known Heart Transplantation</title>
        <description>Heart transplantation after the baseline visit up to 24 months</description>
        <time_frame>6 month intervals after the baseline visit up to 24 months</time_frame>
        <population>Patients with known endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>MedaMACS Participants</title>
            <description>All participants who have met the inclusion criteria.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Known Heart Transplantation</title>
          <description>Heart transplantation after the baseline visit up to 24 months</description>
          <population>Patients with known endpoints.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="171"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>After the baseline visit and up to 24 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>MedaMACS Participants</title>
          <description>All participants who have met the inclusion criteria.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="171"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="93" subjects_at_risk="171"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>IV Inotropes Dependent at 6 months</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="171"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Rehospitalization</sub_title>
                <description>All-cause Rehospitalizations</description>
                <counts group_id="E1" events="273" subjects_affected="93" subjects_at_risk="171"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="171"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>All-location Infection</sub_title>
                <description>All-location Infection</description>
                <counts group_id="E1" events="19" subjects_affected="12" subjects_at_risk="171"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>RongBing Xie</name_or_title>
      <organization>University of Alabama at Birmingham</organization>
      <phone>205-975-3624</phone>
      <email>rongbingxie@uabmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

